In cancer, discussion of action of the NEDD9-CASS4-PTK2B scaffolding and signaling axis almost invariably focuses on the regulation of cell migration and invasion, following the upregulation of NEDD9 and activation of PTK2B in many tumors. The gene discussed is PTK2B; the disease is cancer.